Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer

EP. Slater, LM. Wilke, LB. Böhm, K. Strauch, M. Lutz, N. Gercke, E. Matthäi, K. Hemminki, A. Försti, M. Schlesner, N. Paramasivam, DK. Bartsch

. 2021 ; 11 (7) : . [pub] 20210702

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024449

Grantová podpora
111092 Deutsche Krebshilfe
10001 GAUFF-Foundation

Familial pancreatic cancer (FPC) is an established but rare inherited tumor syndrome that accounts for approximately 5% of pancreatic ductal adenocarcinoma (PDAC) cases. No major causative gene defect has yet been identified, but germline mutations in predisposition genes BRCA1/2, CDKN2A and PALB2 could be detected in 10-15% of analyzed families. Thus, the genetic basis of disease susceptibility in the majority of FPC families remains unknown. In an attempt to identify new candidate genes, we performed whole-genome sequencing on affected patients from 15 FPC families, without detecting BRCA1/2, CDKN2A or PALB2 mutations, using an Illumina based platform. Annotations from CADD, PolyPhen-2, SIFT, Mutation Taster and PROVEAN were used to assess the potential impact of a variant on the function of a gene. Variants that did not segregate with pancreatic disease in respective families were excluded. Potential predisposing candidate genes ATM, SUFU, DAB1, POLQ, FGFBP3, MAP3K3 and ACAD9 were identified in 7 of 15 families. All identified gene mutations segregated with pancreatic disease, but sometimes with incomplete penetrance. An analysis of up to 46 additional FPC families revealed that the identified gene mutations appeared to be unique in most cases, despite a potentially deleterious ACAD9 Ala326Thr germline variant, which occurred in 4 (8.7%) of 46 FPC families. Notably, affected PDAC patients within a family carried identical germline mutations in up to three different genes, e.g., DAB1, POLQ and FGFBP3. These results support the hypothesis that FPC is a highly heterogeneous polygenetic disease caused by low-frequency or rare variants.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024449
003      
CZ-PrNML
005      
20211013133921.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jpm11070631 $2 doi
035    __
$a (PubMed)34357098
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Slater, Emily P $u Department of Visceral, Thoracic and Vascular Surgery, Philipps University, D-35043 Marburg, Germany
245    10
$a Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer / $c EP. Slater, LM. Wilke, LB. Böhm, K. Strauch, M. Lutz, N. Gercke, E. Matthäi, K. Hemminki, A. Försti, M. Schlesner, N. Paramasivam, DK. Bartsch
520    9_
$a Familial pancreatic cancer (FPC) is an established but rare inherited tumor syndrome that accounts for approximately 5% of pancreatic ductal adenocarcinoma (PDAC) cases. No major causative gene defect has yet been identified, but germline mutations in predisposition genes BRCA1/2, CDKN2A and PALB2 could be detected in 10-15% of analyzed families. Thus, the genetic basis of disease susceptibility in the majority of FPC families remains unknown. In an attempt to identify new candidate genes, we performed whole-genome sequencing on affected patients from 15 FPC families, without detecting BRCA1/2, CDKN2A or PALB2 mutations, using an Illumina based platform. Annotations from CADD, PolyPhen-2, SIFT, Mutation Taster and PROVEAN were used to assess the potential impact of a variant on the function of a gene. Variants that did not segregate with pancreatic disease in respective families were excluded. Potential predisposing candidate genes ATM, SUFU, DAB1, POLQ, FGFBP3, MAP3K3 and ACAD9 were identified in 7 of 15 families. All identified gene mutations segregated with pancreatic disease, but sometimes with incomplete penetrance. An analysis of up to 46 additional FPC families revealed that the identified gene mutations appeared to be unique in most cases, despite a potentially deleterious ACAD9 Ala326Thr germline variant, which occurred in 4 (8.7%) of 46 FPC families. Notably, affected PDAC patients within a family carried identical germline mutations in up to three different genes, e.g., DAB1, POLQ and FGFBP3. These results support the hypothesis that FPC is a highly heterogeneous polygenetic disease caused by low-frequency or rare variants.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wilke, Lisa M $u Department of Visceral, Thoracic and Vascular Surgery, Philipps University, D-35043 Marburg, Germany
700    1_
$a Böhm, Lutz Benedikt $u Department of Visceral, Thoracic and Vascular Surgery, Philipps University, D-35043 Marburg, Germany
700    1_
$a Strauch, Konstantin $u Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University, D-55101 Mainz, Germany $u Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Genetic Epidemiology, D-85764 Neuherberg, Germany $u Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, D-81377 Munich, Germany
700    1_
$a Lutz, Manuel $u Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University, D-55101 Mainz, Germany $u Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Genetic Epidemiology, D-85764 Neuherberg, Germany $u Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, D-81377 Munich, Germany
700    1_
$a Gercke, Norman $u Department of Visceral, Thoracic and Vascular Surgery, Philipps University, D-35043 Marburg, Germany
700    1_
$a Matthäi, Elvira $u Department of Visceral, Thoracic and Vascular Surgery, Philipps University, D-35043 Marburg, Germany
700    1_
$a Hemminki, Kari $u German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology, D-69120 Heidelberg, Germany $u German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, D-69120 Heidelberg, Germany $u Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic
700    1_
$a Försti, Asta $u German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology, D-69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), D-69120 Heidelberg, Germany $u German Cancer Research Center (DKFZ), Division of Pediatric Neuro Oncology, German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany
700    1_
$a Schlesner, Matthias $u Bioinformatics and Omics Data Analytics, German Cancer Research Center, D-69120 Heidelberg, Germany $u Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, D-86159 Augsburg, Germany
700    1_
$a Paramasivam, Nagarajan $u Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany
700    1_
$a Bartsch, Detlef K $u Department of Visceral, Thoracic and Vascular Surgery, Philipps University, D-35043 Marburg, Germany
773    0_
$w MED00203320 $t Journal of personalized medicine $x 2075-4426 $g Roč. 11, č. 7 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34357098 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013133918 $b ABA008
999    __
$a ind $b bmc $g 1708327 $s 1144946
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 7 $e 20210702 $i 2075-4426 $m Journal of personalized medicine $n J. pers. med. $x MED00203320
GRA    __
$a 111092 $p Deutsche Krebshilfe
GRA    __
$a 10001 $p GAUFF-Foundation
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Možnosti archivace